Manulife Financial Corp. Continues Asian Focus With John Hancock Spin-Off Rumours

Manulife Financial Corp. (TSX:MFC)(NYSE:MFC) might be looking to get rid of its John Hancock brand, which is good, because the focus needs to be Asia.

| More on:
The Motley Fool

Manulife Financial Corp. (TSX:MFC)(NYSE:MFC) is a financial services company and the largest insurance provider in Canada, counting one in three Canadians as its customers. It also has strong exposure in the United States through the John Hancock brand. Over the past few years, the company has been aggressively expanding into Asian markets.

Back in April, I argued that 2017 would be the “Year of Asia” for the company as it continued to invest heavily in that region. There are billions of people in that part of the world who are only now just starting to reach the middle class. Insurance and financial products are exactly what middle-class people look for to ensure their families are taken care of.

Not to mention, there is going to be an insane amount of wealth transfer as China’s population continues to age, which will create an immense opportunity for Manulife.

Manulife has been preparing for this by making a series of smart partnerships. The company bought the pension business from Standard Chartered Bank, one of the oldest banks in Hong Kong, in September 2015. It also became the exclusive insurance provider until 2030. In January 2016, Manulife signed a similar deal with DBS Bank, which has branches in China, Hong Kong, Indonesia, and Singapore. And in August 2016, the company signed a deal with FTB Bank in Cambodia.

These sorts are deals will pay immense dividends over the coming years as customers from all of those banks begin looking for insurance products.

The numbers support this claim. According to Manulife’s earnings report, it saw a 31% increase in annualized premium equivalent sales compared to this quarter last year. Further, there was a 53% boost in new business value.

Manulife is doubling down on that bet in two ways.

First, its current CEO, Donald Guloien, is retiring in September and will be replaced by Roy Gori, the head of the Asia division.

Second is through the rumoured sale or IPO of its John Hancock brand. According to The Wall Street Journal, Manulife is considering an IPO or spin-off of the John Hancock group. Despite generating 40.4% of the company’s core earnings, John Hancock has underperformed the Canadian and Asian division. Management is likely seeing a small window of opportunity to push John Hancock public and then use those resources to focus on Asia.

Personally, I am all right with that. Manulife bought John Hancock for US$10.4 billion back in 2004. Unfortunately, compared to its competitors, John Hancock is small. While having exposure to the U.S. market is important, Manulife’s history in Asia dates back a century, so it’s simply a better and more lucrative opportunity.

I remain a bull on Manulife because of its focus on Asia. And in the event that the John Hancock brand goes public or is spun off, the returns for Manulife could be significant. And along the way, you can benefit from the 3.25% yield, which is good for a quarterly $0.20 distribution. I said it in April and I’ll say it again: Manulife’s success rests on Asia, and I believe there will be success aplenty.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Jacob Donnelly has no position in any stocks mentioned.

More on Investing

Hand arranging wood block stacking as step stair with arrow up.
Dividend Stocks

1 Growth Stock With Legit Potential to Outperform the Market

Identifying the stocks that have outperformed the market (in the past) is relatively easy, but selecting the ones that will…

Read more »

healthcare pharma
Tech Stocks

Well Health Stock Is Up 7% After Earnings: What Investors Need to Know

Well Health is benefiting from strong demand as it digitizes healthcare and strives to improve patient outcomes.

Read more »

money cash dividends
Dividend Stocks

Passive Income: The Investment Needed to Yield $1,000 Per Annum

Do you want to generate a juicy passive-income stream? Here's a trio of stocks that can generate a yield of…

Read more »

IMAGE OF A NOTEBOOK WITH TFSA WRITTEN ON IT
Dividend Stocks

Here’s the Average TFSA Balance in 2024

The average TFSA balance has steadily risen over the last six years and surpassed $41,510 in 2023. Will the TFSA…

Read more »

Shopping card with boxes labelled REITs, ETFs, Bonds, Stocks
Dividend Stocks

Invest $10,000 in This Dividend Stock for $1,500.50 in Passive Income

If you have $10,000 to invest, then you likely want a core asset you can set and forget. Which is…

Read more »

Supermarket aisle with empty green shopping cart
Stocks for Beginners

Is Dollarama Stock a Buy?

Dollarama stock (TSX:DOL) has seen shares surge on the back of strong performance and a dividend boost, but it also…

Read more »

potted green plant grows up in arrow shape
Dividend Stocks

TFSA Set and Forget: 2 Dividend-Growth Superstars for the Long Run

I'd look to buy and forget CN Rail (TSX:CNR) and another Canadian dividend-growth sensation for decades at a time.

Read more »

Payday ringed on a calendar
Dividend Stocks

1 Passive-Income Stream and 1 Dividend Stock for $781.48 in Monthly Cash

Looking for passive income? Don't take out a loan with that high interest involved. Instead, consider this method for years…

Read more »